Telesis Bio, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TBIO research report →
Companycodexdna.com
Codex DNA, Inc. , a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis.
- CEO
- Eric Esser
- IPO
- 2021
- Employees
- 39
- HQ
- Lexington, MA, US
Price Chart
Valuation
- Market Cap
- $4.00M
- P/E
- -0.03
- P/S
- 0.15
- P/B
- 0.05
- EV/EBITDA
- -0.91
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 61.62%
- Op Margin
- -169.18%
- Net Margin
- -173.49%
- ROE
- -125.42%
- ROIC
- -72.66%
Growth & Income
- Revenue
- $27.51M · 0.27%
- Net Income
- $-47,724,000 · 1.54%
- EPS
- $-1.59 · 3.64%
- Op Income
- $-46,539,000
- FCF YoY
- 15.14%
Performance & Tape
- 52W High
- $1.55
- 52W Low
- $0.00
- 50D MA
- $0.04
- 200D MA
- $0.07
- Beta
- 2.30
- Avg Volume
- 740
Get TickerSpark's AI analysis on TBIO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 24, 24 | Krueger Todd | other | 8,390 |
| Jul 24, 24 | Krueger Todd | other | 5,268 |
| Jul 24, 24 | Golub Steven J | other | 8,390 |
| Jul 24, 24 | Golub Steven J | other | 5,268 |
| Jul 24, 24 | Hlavinka Sarah E. | other | 8,390 |
| Jul 24, 24 | Hlavinka Sarah E. | other | 5,268 |
| Jul 24, 24 | Hodges Michael R. | other | 8,390 |
| Jul 24, 24 | Hodges Michael R. | other | 5,268 |
| Jul 24, 24 | Weissman James B | other | 8,390 |
| Jul 24, 24 | Weissman James B | other | 5,268 |
Our TBIO Coverage
We haven't published any research on TBIO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TBIO Report →